Sodium Chloride 0,9 % With Dextrose 5 % Fresenius 50 mg Solution for infusion.
PDF Leaflet Revision Date: 04 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Source of electrolytes, calories, and water.
Dosage (summary)
Dosage directed by a doctor; monitor blood glucose and electrolytes.
Special Populations
- Renal impairment
- Elderly
- Paediatric patients
Pregnancy & Breastfeeding
Caution in pregnancy; safety not established.
Key Drug Interactions
- Diuretics
- Corticosteroids
- Insulin
Contraindications
- Hypersensitivity to components
- Hypervolaemia
- Severe renal impairment
Common side effects
- Hyperglycaemia
- Hyponatraemia
- Venous irritation
Counselling Points
- Monitor glucose and electrolytes regularly.
- Infuse slowly to minimize irritation.
- Report any signs of hypersensitivity.
Serious warnings
- Risk of hypokalaemia
- Fluid overload
- Hyponatraemic encephalopathy
Important Disclaimer
The Sodium Chloride 0,9 % With Dextrose 5 % Fresenius 50 mg Solution for infusion. professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
